Rare diseases
Investigational molecules
Locations
5 Rue Gardenat Lapostol, 92150 Suresnes, France
Clinical research at Egle Therapeutics includes advanced and/or metastatic solid tumors, with attention to anti-cancer immunotherapy and treatment approaches for unmet oncologic needs. The sponsor’s oncology portfolio centers on adult patients with selected solid malignancies.
This area reflects interest in tumor response, safety, and tolerability within oncology-focused drug development.
Egle Therapeutics runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
